CoreSite Realty Corporation (NYSE:COR) announced that Jeff Finnin has joined the company as Chief Financial Officer. Mr. Finnin will succeed Deedee Beckman effective January 24, 2011. Mr. Finnin brings more than 23 years of leadership experience in finance and accounting to CoreSite. He joins CoreSite from ProLogis, where he served as Managing Director and Chief Accounting Officer for over five years.
CoreSite Realty Corporation owns, develops, and operates data centers in certain data center markets in the United States, including Los Angeles, the San Francisco Bay and Northern Virginia areas, Chicago, and New York City. Its customer base consists of enterprise customers, communications service providers, media and content companies, government agencies, and educational institutions.
Orofino Gold Corp. engages in acquisition, exploration, and development of gold properties in Mexico and Colombia. ORFG has an option to acquire properties in the Sur de Bolivar Department of Colombia South America. ORFG was founded in 2005 and is based in Central, Hong Kong.
La Azul - Senderos de Oro Area
La Azul is one producing artesanal mine in the Senderos de Oro area controlled by ORFG, it is a mixed sequence of predominantly volcanic rocks with the vien systems comprised of high grade chalcopyrite, galena and sphalerite with pyrite in quartz viens.
It has been interpreted (by Shaw 1993) that the metallogenic zonation around the La Azul workings evokes a very viable "hidden porphyry" exploration model. This interpretation and the prospectivity of the area have been confirmed by the Orofino "qualified person" as per the 43-101 rules.
ORFG will move ahead aggressively in the last quarter of 2010 to persue the current interpretations, work programs and drilling will begin soon.
Exploration Potential – La Azul and San Carlos Programs
Senderos de Oro Area
Geologically similar to Angostura and Ventana but higher grade, open at depth and to the west toward La Azul.
The observed metallogenic zonation around Senderos de Oro evokes a very viable "hidden porphyry" exploration model. Based upon exploration carried out to date, it is clear that the area hosts significant resources of gold, copper and silver, which, facilitated by the current database and favorable topography, has generated excellent "fast-trackable" bulk-tonnage or high-grade underground Au-Ag-Cu exploration targets.
La (Mina) Azul/La Estrella
Assays of copper-gold samples ran in excess of 40g/t gold, and contain up to 8% copper, bornite and cholcopyrite.
The interpretation and the prospectivity of this concession has been confirmed by an ORFG Qualified Person (as described by the 43-101 compliant standard).
The area is the site of economic mining activity and it is unlikely that the true grade of gold mineralization has been determined by the crude benefication methods employed by the resident miners.
The existing process of using mercury amalgamation to collect the free gold after grinding, followed by cyanide leach of the crushed material would not, for example, liberate gold tied up in the sulphides.
To learn about ORFG visit: http://www.orofinogold.com
CTS Corporation (NYSE:CTS) announced that management will be presenting at the Thirteenth Annual Needham Growth Conference on Wednesday, January 12, 2011 at the New York Palace Hotel in New York City at 3:30 PM. Speaking for the Company will be Vinod M. Khilnani, Chairman of the Board and Chief Executive Officer.
CTS Corporation engages in the design, manufacture, assembly, and sale of electronic components and sensors, as well as the provision of electronics manufacturing services worldwide. It operates in two segments, Electronics Manufacturing Services, and Components and Sensors.
Enzo Biochem, Inc. (NYSE:ENZ)
Uveitis, an inflammatory disease of the eye, is the third leading cause of blindness in the US, after diabetes and macular degeneration. Autoimmune uveitis is believed to result from an autoimmune reaction to antigens in the eye, specifically the S-antigen and the interphotoreceptor retinoid-binding protein (IRBP). OptiquelT our candidate drug based on ENZ's immune regulation technology platform is a potential therapy for autoimmune uveitis.
There is no known cure for uveitis, a disease that, according to the American Uveitis Society, is newly diagnosed in approximately 38.000 people every year. A particular concern is that it is a major cause of blindness among the younger population, especially in the 25 to 44 age group. Recent research suggests that autoimmune uveitis is significantly under-diagnosed an under-recognized.
While there are steps that can be taken to preserve sight and slow the progress of vision loss, individuals with uveitis are also at increased risks of developing cataracts, glaucoma, or retinal detachment. Current mainstays of therapy, including stestemic steroids and immunosuppressive agents, are associated with significant systemic toxic side effects.
Enzo Biochem, Inc. reported improved sequential results recently for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations.
To learn more about ENZ visit: http://www.enzo.com
DAQQ New Energy Corp. American (NYSE:DQ) announced revised guidance for its fourth quarter ended December 31, 2010. Based on the customer orders and product deliveries, the Company now estimates its fourth quarter shipments of polysilicon to be between 930 to 950 metric tons, or MT, above the high-end of its previous guidance of 825 MT to 850 MT given on November 16, 2010. The Company also shipped approximately 3 to 4 megawatts, or MW, of photovoltaic modules, versus its previous guidance of 4 to 5 MW. Primarily as a result of the increased shipments, total revenues for the fourth quarter 2010 are currently estimated to range between US$75 to US$76 million, also above the high end of its previous range of US$65 to US$69 million.
Daqo New Energy Corp., through its subsidiaries, engages in the manufacture and sale of poly silicon for solar panel makers, photovoltaic module, and electrical equipment in China. It processes poly silicon into ingots, wafers, cells, and modules for solar power solutions.
Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising.